Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CASI Pharmaceuticals

Founders John W Holaday

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 2
Rounds per year 0.06
Lead investments 1
Key employees Soon

Areas of investment

  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biotechnology
Summary

CASI Pharmaceuticals appeared to be the Corporate Investor, which was created in 1991. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Rockville.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the CASI Pharmaceuticals, startups are often financed by Redhill Capital. The meaningful sponsors for the fund in investment in the same round are Panacea Venture, Dalton Venture.

Among the most popular portfolio startups of the fund, we may highlight Juventas. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.

The fund was created by John W Holaday.

The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CASI Pharmaceuticals:
Typical Co-investors
CASI Pharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CASI Pharmaceuticals:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accord Ventures Chiyoda, Japan
Alwin Capital Beijing, Beijing, China
China Electronics Optics Valley Union Holding China, Hubei, Wuhan
China Rundong Auto Group China, Shanghai
CYBRiDGE Japan, Yamanashi, Yamanashi Prefecture
Dorilton Capital New York, New York, United States
Fujimori Kogyo Japan, Tokyo
Galaxy Investment Partners New York, New York, United States
H.I.G. Growth Partners Florida, Miami, United States
Madapan Ventures -
Mercuria Investment Chiyoda, Japan
Meridian Capital Seattle, United States, Washington
Michelin Ventures -
Reflexion Capital France, Ile-de-France, Paris
Senrigan Capital China, Hong Kong, Hong Kong Island
Shenzhen Julin Touzi China, Guangdong, Shenzhen
Tianrun Crankshaft China, Shandong, Weihai
Youdao Beijing, Beijing, China
Zhongyi Mingyuan -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Precision Autoimmune Therapeutics

Health Care
Medical
Therapeutics
$21M08 Jul 2022 Beijing, Beijing, China

Biotechnology
Health Care
Pharmaceutical
$15M09 Jul 2019 Chaoyang City, Liaoning

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CASI Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: